Analystreport

Health Catalyst (HCAT) had its price target lowered by Citigroup Inc. from $2.75 to $1.75. They now have a "neutral" rating on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report